-
艾媒咨询|2021年中国美容美发行业投资机遇及总体趋势研究报告
数据显示,2015-2021年中国美容美发行业市场规模复合增长率为4.0%,2021年市场规模为3863亿元。随着国民生活水平的提高以及对生活品质的不断追求,美容美发业的消费需求旺盛,上下游产业和新兴业态快速发展,预估2022年中国美容美发行业市场规模将突破4000亿元。且值得注意的是,在备案完善、监督加强及违法经营成本提升的背景下,中国化妆品行业将加速整顿,有效保障产品安全及其功效的稳定性,具有较强研发实力的品牌有望占据更大的市场份额。随着新消费群体逐渐成为购买主力,不能快速响应市场的品牌面临淘汰,大规模企业兼并即将到来。
According to the data, the compound growth rate of the market scale of China's beauty salon industry from 2015 to 2021 was 4.0%, and the market scale in 2021 was 386.3 billion yuan. With the improvement of national living standards and the continuous pursuit of quality of life, the consumption demand of beauty salon industry is strong, and the upstream and downstream industries and emerging business forms are developing rapidly. It is estimated that the market scale of China's beauty salon industry will exceed 400 billion yuan in 2022. It is worth noting that under the background of perfect filing, strengthened supervision and increased illegal operating costs, China's cosmetics industry will accelerate the rectification and effectively ensure the stability of product safety and efficacy. Brands with strong R & D strength are expected to occupy a larger market share. As new consumer groups gradually become the main force of purchase, brands that cannot respond quickly to the market are facing elimination, and large-scale enterprise mergers are coming. -
艾媒咨询|2021-2022年中国医美器械产业运行及投资决策分析报告
本报告研究涉及企业/品牌/案例:科医人,复星医药,奇致激光,半岛医疗
伴随着医美市场规模的持续扩大,中国医美器械行业发展前景可期。数据显示,预计2021年中国医美器械市场规模将超过500亿元,同比增长27.8%。从细分赛道来看,近年来,微创和无创已逐渐成为医疗美容的趋势,这就推动了以激光、超声波等能量源为代表的光电类医美器械的发展。从市场格局来看,中国正规医美机构设备的市场份额80%是进口品牌,且中高端市场被飞顿、塞诺龙等海外龙头企业占领。为了改变这一局面,国家及地方先后出台政策鼓励本土医美器械品牌的发展,同时,国有品牌也通过加大自主研发投入和投资并购来扩大市场份额,未来随着下游扩张、需求渗透、技术更新等因素有望加速进口替代。
With the continuous expansion of the medical beauty market, the development prospect of the medical beauty equipment industry in China is promising. According to the data, it is estimated that in 2021, the market size of medical devices in China will exceed 50 billion yuan, with a year-on-year growth of 27.8%. From the perspective of subdivision, in recent years, minimally invasive and non-invasive have gradually become the trend of medical beauty, which promotes the development of photoelectric medical beauty devices represented by laser, ultrasonic and other energy sources. From the perspective of market structure, 80% of the market share of China's regular medical and beauty institutions' equipment is imported brands, and the medium and high-end market is occupied by overseas leading enterprises such as feton and sinolon. In order to change this situation, the state and local governments have successively issued policies to encourage the development of local medical and beauty equipment brands. At the same time, the state-owned brands also expand their market share by increasing independent R & D investment and investment in M & A. in the future, with the downstream expansion, demand penetration, technology update and other factors, it is expected to accelerate the import substitution. -
艾媒咨询|2021年9-10月中国化妆品行业运行数据监测双月报:“双十一” 战报
本报告涉及的案例/品牌/企业:C咖,悦瞳,林清轩
数据显示,今年年初社会消费品零售总额受去年低基数的影响,同比高增。自三月以来中国社会消费品零售总额与化妆品类商品零售值同比增长速度总体呈现下滑趋势。艾媒咨询分析师认为,受中国疫情零星出现以及宏观经济景气度等原因,居民总体消费意愿减弱,如将来疫情仍未解决,或一定程度影响化妆品消费的总体需求。不过,从数据来看,今年美妆护肤类产品线上复购需求多于线下体验需求,且对即时性要求不高,在整体电商经济增速下降的环境下,未来美妆护肤类产品线上销售增速仍能够保持高增长趋势。
Data show that at the beginning of this year, the total retail sales of social consumer goods increased year-on-year due to the impact of last year's low base. Since March, the year-on-year growth rate of China's total retail sales of social consumer goods and the retail value of cosmetics has generally shown a downward trend. iiMedia Research analysts believe that due to the sporadic occurrence of the epidemic in China and the macroeconomic boom, the overall consumption willingness of residents is weakened. If the epidemic has not been solved in the future, it may affect the overall demand for cosmetics consumption to a certain extent. However, from the data, this year, the demand for online re purchase of beauty and skin care products is more than the demand for offline experience, and the requirement for timeliness is not high. Under the environment of declining overall e-commerce economic growth, the growth rate of online sales of beauty and skin care products can still maintain a high growth trend in the future. -
艾媒咨询|2020年中国细胞生物产业和商业应用分析报告
本报告研究涉及企业/品牌/案例:华夏源、复星医药。
中国细胞生物产业类型呈现多样化趋势,细胞生物临床研究不断深化,伴随生态合作的拓展将进一步加速细胞生物产业生态圈的形成,生态圈的完善将在很大限度上推动产业快速发展。数据显示,中国细胞治疗企业融资金额不断增加,从2014年的0.2亿元增长至2019年的28.9亿元。其中,2018年中国细胞治疗企业融资额同比增长706.8%,呈现迅猛发展态势。未来中国细胞生物产业的发展将充满机遇,同时也有挑战并存。后续产业的发展,将在5G、人工智能等新技术应用下加速升级。面临多端变化的市场格局,企业也应积极开展生态合作以及更为密切关注市场需求动向,将疗法和新一代医疗创新技术深度融合,实现市场产品多元化与差异化,并推出独特性的精准治疗,从而最大限度地释放产业价值。
The types of cell biological industry in China show a trend of diversification, and the deepening of cell biological clinical research will further accelerate the formation of the cell biological industry ecosystem with the expansion of ecological cooperation, and the improvement of the ecosystem will promote the rapid development of the industry to a large extent. Data show that the financing amount of Chinese cell therapy enterprises keeps increasing, from 20 million yuan in 2014 to 2.89 billion yuan in 2019. Among them, in 2018, the financing amount of Chinese cell therapy enterprises increased by 706.8% year on year, showing a rapid development trend. In the future, the development of China's cell biology industry will be full of opportunities and challenges. The development of subsequent industries will be accelerated with the application of new technologies such as 5G and ARTIFICIAL intelligence. In the face of the changing market pattern, enterprises should also actively carry out ecological cooperation and pay close attention to the trend of market demand, deeply integrate therapy and new-generation medical innovation technology, realize the diversification and differentiation of market products, and launch unique precision therapy, so as to maximize the release of industrial value. -
艾媒咨询|2020年3-4月中国化妆品及化妆品电商运行数据监测双月报告
本报告研究涉及企业/品牌/案例:壹网壹创,嘉亨家化。
随着国际疫情的衍变,化妆品的用户需求降低和供应链风险增加,令3-4月化妆品行业的压力不容小觑。但从宏观数据看,在3月化妆品价格跌入低谷后,4月有一定的反弹趋势;从平台数据看,2020年4月阿里巴巴全网护肤GMV 为139 亿元,同比增长58.02%。
With the development of the international epidemic, the reduction in user demand for cosmetics and the increase in supply chain risks have made the pressure on the cosmetics industry in March-April not to be underestimated. However, from the macro data, after the price of cosmetics fell into a trough in March, there was a certain rebound trend in April; from the platform data, in April 2020, Alibaba's entire network skin care GMV was 13.9 billion yuan, an increase of 58.02% year-on-year. -
艾媒报告|2020-2021年中国美容美发行业细分领域及总体趋势研究报告
本报告研究涉及企业/品牌/案例:星客多,完美日记,新氧医美;其他提及企业/品牌:海飞丝,阿道夫,沙宣,清扬,潘婷,飘柔,吕,多芬,施华蔻,资生堂,霸王,章光101,欧倍青,卡诗,滋源,丰添,馥绿德雅,索芙特,欧莱雅,花王,美源,爱茉莉,韩金靓,三橡树,利尻昆布,宣若,自然堂,百雀羚,珀莱雅,隆力奇,佰草集,丸美,相宜本草,薇诺娜,毛戈平,雅诗兰黛,兰蔻,SK-II,兰芝,佰草集,高丝,玉兰油、欧莱雅,欧泊莱,旁氏,大宝,郁美净,隆力奇,丁家宜,佳雪,In Style 造型,OnHair Salon,SWANK Salon,My Hair Salon,AUTHOR TNT ATELIER,藤野造型,木北造型,3AM Hair Salon,Amo la Diva 造型,bymiga,OnHair Salon,In Style 造型,藤野造型,P.STYLE 派斯造型,Hair Code 芭曲造型,MG Style Salon,Kraemer Paris 苏豪发廊,TL Hair 造型,3AM Hair Salon,IMPRES 印象美学,In Style 造型,Paya Hair,My Hair Salon,T SPACE 韩式发型,至 ACME STUDIOS,MJ Hair Style,On Star Salon,简发 HAIR 造型,L’Fashion 美发沙龙,AD Hair Salon,DL VOGUE,Cola-Pie 美发沙龙,原宿 Salon,Nice Salon,In Style 造型,OnHair Salon,Mirror Salon,3AM Hair Salon,COO Salon,MIG Salon等
2020年1月21日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020-2021年中国美容美发行业细分领域及总体趋势研究报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对中国美容美发行业的发展现状、用户行为和产业链细分领域进行深度分析,并且以新氧等上市公司作为典型案例进行商情分析,深入研究中国美容美发行业运行模式和发展趋势。2019年,中国的美容美发机构约有95%为民营资本,美容美发行业就业人口达2700万人;总体来说,中国美容美发业整体属于小投资、大市场型的服务行业。随着中国美容美发行业竞争愈发激烈,美容美发机构的经营模式正由单一走向综合,形式也日趋多样化,品牌机构趋向连锁加盟、互联网+实体店融合的经营模式发展。
The report conducts an in-depth analysis of the development status, user behavior and industry chain segmentation of China's beauty and hairdressing industry. Listed companies analyze business conditions as a typical case, and study in-depth the operation mode and development trend of China's beauty and hairdressing industry. In 2019, about 95% of China's beauty and hairdressing institutions are private capital, and the beauty and hairdressing industry employs 27 million people. In general, China's beauty and hairdressing industry as a whole is a small investment and large market-oriented service industry. As the competition in the Chinese beauty and hairdressing industry becomes more intense, the business model of the beauty and hairdressing organization is moving from a single to a comprehensive, and the form is becoming more and more diversified. -
艾媒报告 |2019年中国生物医药产业发展及舆论焦点分析报告
本报告研究涉及企业/品牌包括:Takeda、GSK、Sanofi、Celgene、Novartis、宝洁、CVC Fund VII、Shire、诺华OTC、Bioverativ、Juno Therapeutics、AveXis、Impact Biomedicines、Tesaro、Ablynx、默克OTC、Recordati控股公司FIMEI、复星医药、海正药业、康弘药业、泰合健康、齐鲁制药、复宏汉霖、信达生物、张江生物、恒瑞医药、三生国健、嘉和生物、百奥泰、深圳龙瑞、天坛生物、华兰生物、博雅生物、上海莱士、卫光生物、辽宁成大、智飞生物、康泰生物、沃森生物、利德曼、交大昂立、华润双鹤、力生制药、海欣股份、联环药业、白云山、中源协和、普洛药业
随着生物医药技术不断突破,中国生物医药产业快速发展,2018年,单抗、血液制品、疫苗等生物医药相关领域多家头部上市企业营收均超亿元,实现同比增长。iiMedia Research(艾媒咨询)监测发现,生物医药产业网络言值指数为49.7,网民评价态度偏向正面,上海网民对生物医药产业的关注度最高。未来,随着中国生物医药行业上市公司数量增多,行业与企业间竞争将更加激烈。
The scale of China's bio-pharmaceutical industry continues to grow, and the proportion of bio-pharmaceutical output in the pharmaceutical industry continues to rise. In 2017, the total output value of the bio-pharmaceutical industry in China's park was about 1.5 trillion yuan. At present, China's biomedical industry has formed three major clusters, including the Bohai Rim region, the Yangtze River Delta region and the Pearl River Delta region, and the industrial agglomeration effect is outstanding. China's bio-pharmaceutical industry is in a stage of rapid development. In 2018, many head-to-head listed companies in biomedical related fields such as monoclonal antibodies, blood products and vaccines all exceeded 100 million yuan, achieving year-on-year growth. According to iiMedia Research, netizens in Shanghai are most concerned about the biomedical industry, and 40.9% of netizens surveyed support the application of transgenic technology in the pharmaceutical field. Among the heads of monoclonal antibodies, blood products and vaccines, Fuhong Hanlin as well as Weiguang Bio and Lidmanthe has the best online reputation,iiMedia Consulting analysts believe that in the future, the combination of artificial intelligence with new drug research and the fierce competition among head enterprises is an important trend in the development of China's biomedical industry. -
艾媒报告 |2019全球及中国大健康产业运行大数据及决策分析报告
本报告研究涉及企业/品牌/案例:恒瑞医药,白云山,111集团,平安好医生,好大夫在线,优健康,春雨医生,微医,丁香医生,和美医疗,北大医疗,PHG,新氧,联合丽格,正广兴家庭医生,强森医疗,微脉,美中嘉和,零氪科技,中有精准医疗,思派网络,普瑞眼科,臻和科技,移宇科技,小鹿医馆,妈咪知道,八百方,京东医药,阿里健康大药房,1药网,一心堂,健一网,好药师,健客网,美丽神器,更美,悦美,美莱整形,伊美尔,丽都整形,芝星整形,欧华美科
大健康产业细分领域的垂直深化,推动了大健康产业格局的不断完善。受政策鼓励和资本推动的影响,2019年,大健康产业在患者服务类领域、医疗服务类领域、医药服务类领域、医疗美容类领域和医疗保健类领域等细分场景快速发展。以恒瑞医药、白云山为代表的传统医药上市公司和以平安好医生、111集团和新氧科技为代表的互联网医疗上市企业各自占据大健康产业领域的一席之地。艾媒商情舆情监测系统数据显示,受2018年和2019年上半年医疗领域负面舆情的影响,大健康产业各上市企业正从低谷平稳回升。艾媒咨询分析师认为,受社会医疗需求和国家政策的推动,大健康产业仍是未来投资的亮点。
The vertical deepening of the large health industry segment has promoted the continuous improvement of the pattern of the big health industry. Influenced by policy encouragement and capital promotion, in 2019, the big health industry developed rapidly in the sub-sectors such as patient service, medical services, medical services, medical and beauty, and health care. The traditional pharmaceutical listed companies represented by Hengrui Medicine and Baiyun Mountain and the Internet medical listed companies represented by Ping An Doctor, 111 Group and New Oxygen Technology each occupy a place in the field of large health industry. According to data from the Aibu Business Intelligence Monitoring System, the listed companies in the big health industry are recovering steadily from the bottom of the market due to the negative public sentiment in the medical field in the first half of 2018 and 2019. Ai Media Consulting analysts believe that the health industry is still the highlight of future investment, driven by social medical needs and national policies.
- 1
- 2
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告